http://www.europeanpharmaceuticalreview.com Fri, 03 Feb 2012 08:56:11 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://www.europeanpharmaceuticalreview.com/11017/news/industry-news/fda-approves-janumet-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes/ http://www.europeanpharmaceuticalreview.com/11017/news/industry-news/fda-approves-janumet-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes/#comments Thu, 02 Feb 2012 16:51:00 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=11017 http://www.europeanpharmaceuticalreview.com/11017/news/industry-news/fda-approves-janumet-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes/feed/ 0 http://www.europeanpharmaceuticalreview.com/10990/news/industry-news/astrazeneca-to-cut-a-further-7300-jobs/ http://www.europeanpharmaceuticalreview.com/10990/news/industry-news/astrazeneca-to-cut-a-further-7300-jobs/#comments Thu, 02 Feb 2012 09:59:33 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10990 http://www.europeanpharmaceuticalreview.com/10990/news/industry-news/astrazeneca-to-cut-a-further-7300-jobs/feed/ 0 http://www.europeanpharmaceuticalreview.com/10984/news/industry-news/fda-approves-novartis-drug-glivec-label-recommending-extending-treatment-to-three-years-for-certain-gist-patients-after-surgery/ http://www.europeanpharmaceuticalreview.com/10984/news/industry-news/fda-approves-novartis-drug-glivec-label-recommending-extending-treatment-to-three-years-for-certain-gist-patients-after-surgery/#comments Wed, 01 Feb 2012 11:58:28 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10984 http://www.europeanpharmaceuticalreview.com/10984/news/industry-news/fda-approves-novartis-drug-glivec-label-recommending-extending-treatment-to-three-years-for-certain-gist-patients-after-surgery/feed/ 0 http://www.europeanpharmaceuticalreview.com/10977/whitepapers/whitepaper-autoantibody-biomarker-panels-for-improved-disease-diagnosis/ http://www.europeanpharmaceuticalreview.com/10977/whitepapers/whitepaper-autoantibody-biomarker-panels-for-improved-disease-diagnosis/#comments Wed, 01 Feb 2012 09:46:26 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10977 http://www.europeanpharmaceuticalreview.com/10977/whitepapers/whitepaper-autoantibody-biomarker-panels-for-improved-disease-diagnosis/feed/ 0 http://www.europeanpharmaceuticalreview.com/10952/news/industry-news/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020/ http://www.europeanpharmaceuticalreview.com/10952/news/industry-news/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020/#comments Mon, 30 Jan 2012 17:15:37 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10952 http://www.europeanpharmaceuticalreview.com/10952/news/industry-news/private-and-public-partners-unite-to-combat-10-neglected-tropical-diseases-by-2020/feed/ 0 http://www.europeanpharmaceuticalreview.com/10950/news/industry-news/novartis-extends-commitment-to-help-achieve-final-elimination-of-leprosy/ http://www.europeanpharmaceuticalreview.com/10950/news/industry-news/novartis-extends-commitment-to-help-achieve-final-elimination-of-leprosy/#comments Mon, 30 Jan 2012 17:10:14 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10950 http://www.europeanpharmaceuticalreview.com/10950/news/industry-news/novartis-extends-commitment-to-help-achieve-final-elimination-of-leprosy/feed/ 0 http://www.europeanpharmaceuticalreview.com/10971/news/industry-news/fda-approves-jentadueto-linagliptinmetformin-hydrochloride-tablets-for-the-treatment-of-adult-patients-with-type-2-diabetes/ http://www.europeanpharmaceuticalreview.com/10971/news/industry-news/fda-approves-jentadueto-linagliptinmetformin-hydrochloride-tablets-for-the-treatment-of-adult-patients-with-type-2-diabetes/#comments Mon, 30 Jan 2012 11:12:06 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10971 http://www.europeanpharmaceuticalreview.com/10971/news/industry-news/fda-approves-jentadueto-linagliptinmetformin-hydrochloride-tablets-for-the-treatment-of-adult-patients-with-type-2-diabetes/feed/ 0 http://www.europeanpharmaceuticalreview.com/10965/news/industry-news/biogen-idec-appoints-kenneth-dipietro-executive-vice-president-human-resources/ http://www.europeanpharmaceuticalreview.com/10965/news/industry-news/biogen-idec-appoints-kenneth-dipietro-executive-vice-president-human-resources/#comments Mon, 30 Jan 2012 10:57:04 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10965 http://www.europeanpharmaceuticalreview.com/10965/news/industry-news/biogen-idec-appoints-kenneth-dipietro-executive-vice-president-human-resources/feed/ 0 http://www.europeanpharmaceuticalreview.com/10958/news/industry-news/sanofi-commits-to-eliminate-or-control-five-neglected-tropical-diseases/ http://www.europeanpharmaceuticalreview.com/10958/news/industry-news/sanofi-commits-to-eliminate-or-control-five-neglected-tropical-diseases/#comments Mon, 30 Jan 2012 10:33:46 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10958 http://www.europeanpharmaceuticalreview.com/10958/news/industry-news/sanofi-commits-to-eliminate-or-control-five-neglected-tropical-diseases/feed/ 0 http://www.europeanpharmaceuticalreview.com/10955/news/industry-news/fda-approves-erivedge-vismodegib-capsule/ http://www.europeanpharmaceuticalreview.com/10955/news/industry-news/fda-approves-erivedge-vismodegib-capsule/#comments Mon, 30 Jan 2012 10:27:51 +0000 pmccartney http://www.europeanpharmaceuticalreview.com/?p=10955 http://www.europeanpharmaceuticalreview.com/10955/news/industry-news/fda-approves-erivedge-vismodegib-capsule/feed/ 0